Cairo – Mubasher: The extraordinary general meeting (EGM) of Ibnsina Pharma approved a proposal to increase the issued capital through a bonus issue, according to a bourse statement on Tuesday.
Earlier in April, the company’s ordinary general meeting (OGM) agreed on a 0.17-for-one bonus issue at a total value of EGP 35 million to increase the capital to EGP 240 million.
It is noteworthy to mention that in 2019, the Egyptian firm reported net profits of EGP 328.77 million, up from EGP 262.5 million in 2018.
